Search Tag: contrasts
2015 14 Jul
Approval based on data demonstrating the pharmacokinetic and safety profiles of Gadovist at standard dose (0.1 mmol/kg) were similar to adults and children 2 years of age and older Diagnostic use in approved indications has been expanded to include use in pediatric patients less than 2 years of age, including term newborns New expanded use...Read more